Bayesian adaptive randomization trial of intravenous ketamine for veterans with late-life, treatment-resistant depression

More than eleven million U.S. Veterans are at least 65 years of age, an age group of which almost 20% suffers from clinically significant depressive symptoms. Available pharmacological treatments are suboptimal for patients, including veterans, with late-life depression. Ketamine has emerged as a po...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Contemp Clin Trials Commun
Egile Nagusiak: O'Brien, Brittany, Green, Charles E., Al-Jurdi, Rayan, Chang, Lee, Lijffijt, Marijn, Iqbal, Sidra, Iqbal, Tabish, Swann, Alan C., Mathew, Sanjay J.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Elsevier 2019
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6727003/
https://ncbi.nlm.nih.gov/pubmed/31508531
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.conctc.2019.100432
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak